Clincosm LogoSign in Get a demo

abuse potential

Showing 1 - 6 of 6
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Abuse Potential Trial in Overland Park (Placebo, Alprazolam 2 mg, Gabapentin Enacarbil Immediate Release (GE-IR) 200 mg)

Completed
  • Abuse Potential
  • Placebo
  • +4 more
  • Overland Park, Kansas
    Altasciences Clinical Kansas
Oct 19, 2023

Healthy Non-dependent, Recreational Sedative Users, Abuse Potential Trial in Overland Park, Montreal (Suvorexant, Zolpidem,

Recruiting
  • Healthy Non-dependent, Recreational Sedative Users
  • Abuse Potential
  • Overland Park, Kansas
  • +1 more
Jan 31, 2023

Abuse Potential Trial in Salt Lake City (gabapentin 600 mg, gabapentin 1200 mg, gabapentin 1800 mg)

Completed
  • Abuse Potential
  • gabapentin 600 mg
  • +4 more
  • Salt Lake City, Utah
    Pharmaceutical Research Associates, Inc.
Dec 22, 2022

Abuse Potential Trial in Marlton (gabapentin 600 mg, gabapentin 1200 mg, gabapentin 600 mg and oxycodone HCl 20 mg)

Completed
  • Abuse Potential
  • gabapentin 600 mg
  • +5 more
  • Marlton, New Jersey
    Hassman Research Institute
Mar 31, 2022

Abuse Potential Trial in Marlton (Pregabalin 300mg, pregabalin 450 mg, Pregabalin 300 mg with oxycodone 20 mg)

Recruiting
  • Abuse Potential
  • Pregabalin 300mg
  • +5 more
  • Marlton, New Jersey
    Hassman Research Institute
Mar 2, 2022

Abuse Potential Trial in Toronto (Tozadenant, Placebo oral tablet, d-amphetamine)

Terminated
  • Abuse Potential
  • Toronto, Ontario, Canada
    INC Research Toronto, Inc.
Aug 9, 2018